Hepatitis B Vaccine (Recombinant) Completed Phase 3 Trials for Neisseria Meningitidis / Virus Diseases / Bacterial Infections Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT01553279Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)
NCT01839188Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)
NCT01480258Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)
NCT01340937A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)
NCT01337167Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)